No question about it: Express Scripts, the country's largest pharmacy benefit manager, just took a big hit. Shares are down about 20% since some unmistakably pessimistic language filling a recent earnings release. But is this really a reason to jump ship? In this video, Motley Fool health-care analyst Brenton Flynn outlines a trio of trends that support the bull argument for Express Scripts longer term.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
3 Trends Driving Express Scripts Forward
NASDAQ: ESRX
Express Scripts Holding Company

Things might not be as bad as feared.
Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool owns shares of Express Scripts. Motley Fool newsletter services recommend Express Scripts. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.